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CHAPTER I 
INTRODUCTION 
Evidence suggests that insulin resistance, a notable metabolic disorder, 
sharply increases the risk of developing chronic disorders such as diabetes and 
cardiovascular disease, as well as their risk factors such as hypertension, glucose 
intolerance, and hyperlipidemia (Matsumoto et aI., 1999; Taniguchi et aI., 2000; 
Lind et al., 1993). Over 700,000 people died of heart disease in the United 
States in 1999 (National Vital Statistics Reports, 2001). At an alarming rate, new 
cases of diabetes are diagnosed each year. Diabetes is the single leading cause 
of kidney disease and is a risk factor for coronary heart disease eCHD) and stroke 
(American Diabetes Association, 2002). Diabetes is also a major contributor to 
blindness, nerve damage, high blood pressure,and amputations. ImprOVing diet 
quality would not eliminate these serious health risks, but could reduce the 
current health burden associated with diet-related conditions by delaying and 
preventing the onset of these diseases (King et aI., 1998; Davidson, 1998; 
Bloomgarden, 2000; Franz et aI., 1994). 
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Background and Significance of the Problem 
Adults who consume diets that are high in saturated fat or carbohydrates 
are at increased risk for development of insulin resistance (Feskens et aI., 1995,; 
Riccardi & Rivellese, 2000). Studies show that diets high in saturated fats and 
simple sugars promote increased insulin responses (Storlien, 2000), but the 
effect of protein on insulin resistance is not well-studied. Costa et al. (2000) 
found that protein intake was not associated with blood glucose concentration in 
a high risk Japanese-Brazilian population. However, another study found that 
animal protein and fat intake were higher in Japanese-American men who were 
later diagnosed with diabetes than in nondiabetic men (Tsunehara et aI., 1990). 
Examining data from a large nationally representative sample will help determine 
if there is an association between protein intake and glycemic profiles in the 
United States population. 
Low calorie diets and weight loss are associated with reduced insulin 
resistance (American Diabetes Association, 1997). In recent years, dietary 
guidance for weight loss has focused on encouragingi adults to lower their fat 
intake, however too much emphasis on increasing carbohydrate intake may 
worsen glycemic control in adults who are insulin sensitive (Riccardi & Rivellese, 
2000). Therefore, diets that are lower in fat and carbohydrate but higher in 
protein may promote weight loss with better glycemic control. In individuals 
with diabetes, consumption of di.etary protein may promote metabolic control by 
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extending the time substrates are available for hepatic glucose production and 
result in a lower glycemic response than glucose (Franz et aL, 1994). 
Studies examining the impact of protein on blood lipid levels are not 
conclusive. One study found no difference in lipoprotein profiles by protein 
intake after using analysis of covariance (ANCOVA) adjusted for sex and age 
effects (Lamon-Fava et aL, 1994). However, Smit et aL (1999A) found that 
subjects in the highest quartile of serum cholesterol consumed more animal 
protein than subjects in the lowest quartile using age-, sex-, and race-adjusted 
values. In a Swedish cohort study, adults who ate more protein often consumed 
more saturated fat and less complex carbohydrate after adjusting for differences 
in energy intake (Elmstahl et aI., 1999). The consumption of very lean meats as 
part of low fat diets has resulted in reduced blood lipid concentrations (DaVidson 
et aI., 1999; Bales 1995; SCott 1994). 
Purpose of Study and Hypotheses 
Insulin resistance and the development of chronic diseases are probably 
linked through changes in lipid and glucose metabolism (Cruz et aL, 2001; Greco, 
et aL, 2002; American Diabetes Association, 1998; Ozaki et aI., 2002; Pyorala M, 
et aL, 2000; Colagiuri et aL, 2002; Fujimoto, 2000; Und et aI., 1993). Adults 
who are at risk of insulin resi'stance may enhance their glycemic control without 
elevating lipoproteins if they consume a high protein diet. The purpose of this 
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study was to examine the relationship of protein intake with lipoprotein and 
glycemic profiles in US adults who are at risk of insulin resistance. To address 
this purpose, we examined data from the Third National Health and Nutrition 
Examination Survey (1988-1994). 
Objective of Study 
The following questions were identified as being relevant to the problem. 
These questions were used to develop the specific hypotheses of the study: 
1.	 What is the relation between protein intake and glycemic profiles (glucose, 
insulin, C-peptide, and hemoglobin Ale) in adults at risk of insulin 
resistance? 
2.	 What is the relation between protein intake and lipoprotein profiles (total 
cholesterol, LDL cholesterol, HDL cholesterol, triglycerides) in adults at 
risk of insulin resistance? 
Research Hypotheses 
The follOWing research hypotheses were developed for this study: 
1.	 Glycemic profiles (glucose, insulin, C-peptide, and hemoglobin Ale) will be 
I 
associated with quartiles of total and animal protein intake in adults at risk 
of insulin resistance. 
1-A. Glycemic profiles will be positively associated with quartiles of total and 
animal protein intake in adults at risk of insulin resistance. 
1-B. Glycemic profiles will be negatively associated with protein intake in 
adults at risk of insulin resistance. 
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2. Lipoprotein profiles (total cholesterol, LDL cholesterol, HDL cholesterol, 
triglycerides) will be associated with quartiles of total and animal protein 
intake in adults at risk of insulin resistance. 
2-A. Lipoprotein profiles will be positively associated with quartiles of total 
and animal protein intake in adults, at risk of insul,in resistance. 
Assumptions and Limitations 
The study will be based on the following assumptions and limitations: 
Assumptions of the Study 
1.	 True information was prOVided by respondents. 
2.	 All questions were of equal difficulty for each respondent. 
3.	 The nutrient intake reported will accurately represent the usual food 
intake. 
Limitations of the Study 
1.	 Data were self reported. 
2.	 The accuracy of dietary assessment methods depends on the respondent's 
perception of the portion sizes. 
3.	 The use of memory to record the foods is a limitation because there are 
many food that are easy to forget. 
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Definition of Terms 
Adults at risk of insulin resistance: adults who are obese (males with a body 
mass index >27.8 kg/m2; and females with a body mass index >27.3 kg/m2), 
have a family history of diabetes mellitus, high waist circumference (males 
>102cm; and females >97cm), impaired fasting glucose (the blood glucose 
concentrations above 6.1 mmoljL), or mildly elevated triglycerides (150 and 499 
mg/dL). (Dickey et aI., 1998; Wangerin-Lile et aI., 2000; Unwin N et aL, 1998; 
NCEP,2001) 
Diabetes mellitus: a metabolic disease in which carbohydrate utilization is 
reduced and that of lipid and protein enhanced; it is caused by an absolute or 
relative deficiency of insulin and is characterized, in more severe cases, by 
chronic hyperglycemia, glycosuria, water and electrolyte loss, ketoacidosis, and 
coma; long-term complications include development of neuropathy, retinopathy, 
nephropathy, generalized degenerative changes in large and small' blood vessels, 
and increased susceptibility to infection (Mahan et aL, 1996; Whitney et aI., 
, 
1994).
 
Glycemic Drofile: serum glucose, plasma glucose, serum insulin, serum C-

peptide, and glycated hemoglobin.
 
Insulin resistance: the condition in which a normal amount of insulin produces a
 
subnormal effect; a metabolic consequence of obesity; a common cause of non-

insulin-dependent diabetes (Mahan et aI., 1996; Whitney et aI., 1994).
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Upid profile: total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. 
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CHAPTER II 
REVIEW OF RELATED LITERATURE 
Insu.lin Resistance 
Insulin is a hormone that has a variety of effects on many types of cells. 
Anabolic actions of insulin on glucose, lipid, and protein metabolism are essential 
for life. A lack of insulin will lead to extreme hyperglycemia and hyperlipidemia, 
protein wasting, and ultimately, keto-addosis and death. Although insulin is 
essential for various metabolic systems, its chief control is exerted over glucose 
metabolism (Ferrannini et aI., 1999). 
The circulating glucose concentration is a highly homeostatic variable. A 
rise in plasma glucose concentrations, whether induced by an exogenous 
(alimentary) or endogenous (hepatic) input, stimulates insulin secretion. Post­
prandial surges and inter-prandial declines of insulin level are tightly coupled to 
glucose availability and prevent both hypoglycemia and hyperglycemia. Thus, 
the proper response of pancreatic r3-cells to glycemic changes by punctually 
increasing or decreasing insulin release is the conclusive factor to glucose control 
(Cheatam & Kahn, 1995; Fujimoto, 2000). 
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Insulin resistance is generally defined as an impaired response to the 
effect of high insulin concentrations (either exogenous or endogenous) on 
glucose metabolism. According to Consensus Development Conference on 
Insulin Resistance, the concept of insulin resistance contains any of the biological 
actions affected by insulin, such as lipid and protein metabolism, vascular 
endothelial function, and gene expression (American Diabetes Association, 1998). 
Insulin resistance is a condition that requires greater than normal insulin levels to 
bring forth a normal glucose concentration in the whole body, a tissue, or at the 
cellular level. Insulin resistance results from diminished insulin action or 
decreased insulin sensitivity (Krentz, 1996; Colagiuri & Miller, 2002). 
Insulin resistance can be quantified directly with the euglycemic 
hyperinsulinemic clamp technique or other methods, such as intravenous glucose 
tolerance test and fasting insulin concentrations. Intravenous glucose tolerance 
test and euglycemic hyperinsulinemic clamp technique are not suitable 
experimental methods for epidemiological studies, and for this reason fasting 
insulin is commonly used as an estimate of insulin resistance (Ferrannini & Mari, 
1998). Also, quantitative comparisons of resistance to the action of insulin are 
difficult between populations and between individuals because of the need to 
standardize for physiological~ (age, gender, race, physical fitness), pathological 
(obesity, glucose tolerance, blood pressure, hormonal effects) and genetic 
factors. Thus, an individual with normal glucose tolerance who is in the highest 
quartile of insulin concentrations of the population may be considered to be 
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insulin resistant (Colagiur" & Miller, 2002; McAuley et aL, 2001). There is no 
generally acceptable quantitative definition of insulin resistance and therefore of 
what constitutes normal or abnormal insulin concentration (Ferrannini & Mari, 
1998). The homeostasis model assessment (HOMA) provides a simple index for 
evaluating insulin sensitivity from a single sample, which is closely correlated 
with insulin resistance index assessed by euglycemic clamp in type 2 diabetic 
patients, however clinical use is limited (Kanauchi et aL, 2002; Fukushima et aL, 
2000). 
several studies have revealed the link between insulin resistance and 
various pathophysiological conditions that are coupled with metabolic 
disturbances such as type 2 diabetes, impaired glucose tolerance, cardiovascular 
disease, hypertension, dyslipidemia (high triglycerides, low HDL-cholesterol, and 
smaller, denser LDL particles), and obesity (Ambrosch et al., 1998; Hauner, 
2002). According to the Insulin Resistance Atherosclerosis study that examined 
the relationship between insulin sensitivity and the risk of diabetes and 
cardiovascular disease by measuring fasting concentrations of Insulin and acute 
insulin response among adults who were nondiabetic, insulin resistance 
independently predicted development of type 2 diabetes (Hanley et al., 2002). 
Matsumoto et aL (1999 & 2001) reported that insulin resistance was an 
independent risk factor for ischemic stroke in Japanese patients with type 2 
diabetes along with aging and hypertension. 
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Taniguchi et at (2000) compared the cardiovascular disease risk factors in 
Japanese type 2 diabetes patients with normal insulin sensitivity and insulin 
resistance and found that patients with normal insulin action have a low 
cardiovascular disease risk, whereas those with insulin resistance have a 
significantly increased cardiovascular disease risk. Also, patients with insulin 
resistance exhibited higher bOOy mass index (BMI) and triglyceride levels than 
patients with normal insulin sensitivity. According to Lind et al. (1993), insulin 
resistance, measured by the euglycemic hyperinsulinemia clamp technique, was 
a better predictor of cardiovascular ,risk factors including hypertension, glucose 
intolerance, and indices of hyperlipidemia (elevated free fatty acids, serum 
triglycerides and low HDL cholesterol) than hyperinsulinemia, but both insulin 
sensitivity and hyperinsulinemia were significantly related to fasting glucose 
concentrations. 
Obesity is a common cause of insulin resistance and poses a major risk for 
the development of diabetes (Caro, 1991). Abnormal fat deposition within 
skeletal muscle has been identified as a mechanism of obesity-associated insulin 
resistance (Greco et aI., 2002). The accumulation of intra-abdominal or visceral 
fat had the strongest association with insulin resistance (Kissebah & Peiris, 1989; 
Lean et aI., 1995)., Ferrannini et al. (1997) reported that the prevalence of 
insulin hypersecretion was greater than the prevalence of insulin resistance in 
nondiabetic, normotensive obese subjects, particularly in women with central 
obesity. 
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Dietary habits are an important environmental factor associated with the 
development of glucose intolerance and insulin resistance. High fat diets 
induced insulin resistance in animal experiments (Storlien et aI., 1991; Kusunoki 
et ai, 1995). In humans, high fat diets have been reported to result in decreased 
insulin sensitivity (lichtenstein & SChwab, 2000). The results of a follow-up 
study conducted on Japanese-Americans living in Hawaii and Los Angeles 
suggested that the westernization of lifestyle such as, conversion to a diet 
containing markedly more animal fat, simple carbohydrates, and less complex 
carbohydrates increased the risk of insulin resistance, hyperinsulinemia, and type 
2 diabetes among migrant Japanese-Americans (Hara et aL, 1996). Similar 
unfavorable dietary changes were observed with Japanese-Brazilians, but the 
study did not confirm the association between dietary habits and the ris'k of type 
2 diabetes (Costa et aLi 2000). In another longitudinal study, higher plasma 
insulin was associated with consumption of more total and saturated fat and less 
carbohydrate and fiber after adjusting for age, gender, ethnicity, physical activity, 
BMI, waist circumference, and total energy (Marshall et aL, 1997). 
Other lifestyle choices also influence the development of insulin resistance 
and associated metabolic conditions and diseases. Increased physical fitness, 
weight reduction, smoldng cessation, and moderate alcohol consumption are 
reported to enhance insulin sensitiVity and improve insulin resistance (Krentz, 
1996). Lower physical activity was observed among Japanese-Americans who 
12
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exhibited diminished earty insulin release to an oral glucose challenge and 
increased insulin resistance characterized by hyperinsulinemia (Hara et aI., 1996). 
The identification of insulin resistance at an early stage is beneficial and 
encouraged, since the metabolic defects associated with some acquired forms of 
insulin resistance, such as obesity are potentially fully reversible, while others 
such as type 2 diabetes and cardiovascular disease are only partially reversible 
(American Diabetes Association, 1998; Martin et al., 1992; Krentz, 1996). 
Metabolic Syndrome 
Insulin resistance is a common underlying abnormality in a number of 
chronic conditions, which cluster together and have collectively been referred to 
as the 'metabolic syndrome.' Originally, Reaven (1988) proposed that insulin 
resistance was at the center of and pathophysiologicaly link to a syndrome 
characterized by a clustering of metabolic abnormalities associated with 
increased cardiovascular risk, impaired glucose tolerance, type 2 diabetes 
mellitus, dyslipidemia, hypertension and obesity (Everson et al., 1998; Hauner, 
2002). The most common feature of metabolic syndrome is insulin resistance, 
then abdominal fat distribution, high tissue concentrations of triglycerides, and 
general or central obesity (Anderson, 2001). According to a study conducted in 
a Chinese population, the most influential factor associated with metabolic 
syndrome included general and central adiposity, impaired insulin sensitivity, and 
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glucose intolerance. Th.e second factor included hypertension and general and 
central obesity. Elevated plasma> triglycerides and low HDL-cholesterolloaded 
very highly on the third factor, and waist circumference was weakly associated. 
The study suggested that the clustering of variables in metabolic syndrome was 
the result of multiple factors linked by adiposity and not a single etiology 
(Anderson et aI., 2001). 
Everson et al. (1998) reported that hypertension, hyperinsullnemia, and 
dyslipidemia (low HDL-cholesterol and high serum triglycerides) were identified 
with insulin resistance. They found that obesity, particularly a weight gain from 
early aduldhood to middle age was independently associated with metabolic and 
hemodynamic abnormalities in men. Each 5% weight gain over reported weight 
at age 20 was associated with 20% increased risk of insulin resistance syndrome 
by middle age after adjusting for age and height. Their findings were 
independent from subjects' age, height, physical acitivity, smoking, education, 
and parental history of diabetes. Fasting hyperinsulinemia in association with the 
clustering of cardiovascular disease risk factors such as glucose intolerance, 
central adiposity, hypertension, and elevated triglycerides and lowered HDL 
cholesterol levels were characteristics of metabolic syndrome in native Hawaiians 
(Mau et aI., 1997). 
Several studies pointed to the association between metabolic syndrome 
and obesity, especiarly central obesity. As suggested by Barker's (1994) fetal 
origins hypothesis, Yajnik (2001) found that small size at birth (or poor fetal 
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growth) and subsequent obesity was associated with increased risk of insulin 
resistance syndrome (diabetes, hypertension, and coronary heart disease) in 
later life among an Indian population. Yajnik also reported that adults from 
India with higher body fat for a given BMI, central adiposity, and small muscle 
mass were at increased risk of insulin resistance. Similar results were reported 
for a Japanese population. Takami et al. (2000) examined the association 
between precise alxlominal' fat distribution and cardiovascular disease and 
reported that alxl:ominal fat, regardless of its intraalxlominal or subcutaneous 
localization, was closely associated with atherosclerotic metabolic factors 
(glucose tolerance, insulin reSistance, serum triglyceride, HDL cholesterol, and 
systolic blood pressure) and predicts carotid atherosclerosis. On the other hand, 
central adiposity and hypertension were not independently associated with 
insulin resistance syndrome among native Hawaiian population (Mau et at, 
1997). 
The results of the Oslo Diet and Exercise Study suggested that an 
intervention of diet and exercise was the most effective treatment in reversing 
the development of insulin resistance syndrome. Diet intervention, which 
included increased intake of fish and reduced total fat intake, was more effective 
in reducing fasting serum levels of glucose, insulin resistance, 8MI, and mean 
blood pressure, while the exercise intervention was more effective in reducing C­
peptides and triglycerides (Torjesen et aI., 1997) 
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It is unlikely that environmental factors such as the intrauterine 
environment, early life nutrient intake, increasing age, overweight, 'lack of 
physical activity, poor diet, starvation, and pregnancy (for gestational diabetes) 
act independently to determine metabolic syndrome or insulin resistance 
syndrome (Anderson et ai, 2001). 
Glycemic Control 
In 1997 the Expert Committee of the American Diabetes Association (ADA) 
and in 1998 the World Health Organization (WHO) proposed a new classification 
and diagnostic criteria for diabetes mellitus. ADA encourages the use of fasting 
glucose as the main diagnostic test of diabetes rather than the oral ,glucose 
tolerance test (OGTT) as recommended by WHO. Current WHO criteria defined 
diabetes as ~ 11.1 mmol/L (~ 200 mg/dl) and impaired glucose tolerance as 7.8 
to 11.0 mmol/l (140 to 198 mg/dl) based on 2 hour post glucose load venous 
plasma values. Using the new ADA criteria, diabetes was defined as fasting 
venous plasma ~ 7.0 mmol/L (~ 126 mg/dL) and impaired fasting glucose as 6.1 
to 6.9 mmol/l (110 to 124 mg/dL). Unwin et al. (1998) examined the 
relationship between normal, impaired, and diabetic categories using the new 
ADA fasting and WHO 2 hour post glucose load criteria using population-based 
data from three ethnic groups (824 European, 375 Chinese, and 680 South Asian) 
aged 25 to 74 years in UK. The prevalence of diabetes was higher based on the 
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ADA criteria, using fasting plasma glucose only, than based on WHO criteria in all 
ethnic groups. 
Some researchers reported another effective diagnostic tool for diabetes. 
Peters et aL (1996) investigated studies reported between 1966 and 1994 in 
which glycosylated hemoglobin (HbA1c) levels, which accurately reflects the 
average blood glucose level for three months, were measured concurrently with 
performance of OGTT and found that measurement of HbA1c levels may 
represent a reasonable approach to identifying treatment-requiring diabetes. 
The study conducted in Japan found high correlations among all three measures 
of glycemic control: fasting plasma glucose, 2 hour plasma glucose in OGTT, 
and HbA1c (Ito et aL, 2000). 
Rising blood sugar levels may harm the body directly, by damaging blood 
vessels throughout the body. It is also a signal of metabolic disorders and 
insulin resistance that sharply increase the risk of developing diabetes, 
cardiovascular disease, and possibly cancer (Guerrero-Igea et al., 2001; Harvard 
Heart Letter, 1998; Toeller, et aL, 2001). Thus, maintenance of as near-normal 
blood glucose levels as possible (glycemic control), along with achieving optimal 
lipid levels is important for prevention and treatment of insulin resistance and its 
associated metabolic diseases and conditions, such as hyperinsulinemia, 
hyperglycemia, hypoglycemia, diabetes mellitus, hypertension, cardiovascular 
disease, and renal disease (Feskens, et aI., 1995; Franz,et aL, 1994). 
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Glycemic control may be improved by regular aerobic exercise, weight 
maintenance and reduction, smoking cessation, and consumption of a healthy 
diet (ADA, 2002). Since a high intake of fat, especially that of saturated fatty 
acids, contributes to the risk of glucose intolerance and type 2 diabetes, eating 
foods such as fish, lean meat, vegetables, and tegumes along with reducing 
caloric intake and spacing of meals may have a protective effect (Franz et aL, 
1994; Feskens et aL, 1995; King et aL, 1998). 
Control of Dyslipidemia. 
Dyslipidemia is a disorder characterized by hypercholesterolemia, 
hyperlipidemia, and hypertriglyceridemia. Dyslipidemia is associated with a high 
risk of cardiovascular disease. Other risk factors common in patients with 
dyslipidemia are android obesity, insulin resistance, type 2 diabetes, and 
hypertension (Haffner, 1998). Alterations in lipid metabolism such as elevated 
plasma triglycerides, decreased plasma HDl cholesterol, and small dense lDL 
particle distribution are commonly associated with insulin resistance. An 
impairment of postprandial lipid metabolism may be an underlying cause linking 
insulin resistance and the development of cardiovascular disease, since insulin 
plays a central role in determining trig,lyceride clearance via activation of 
lipoprotein lipase, and also triglyceride output, through effects on the synthesis 
and secretion of very low density lipoprotein (VLDL). A delay in plasma 
18 
lipoprotein triglycerides clearance allows for -cholesterol esters to be passed on 
rom LDL cholesterol and HDL cholesterol to triglyceride-rich particles, making 
them potentially atherogenic (Cruz et aI., 2001). 
Third Report of the National Cholesterol Education Program (NCEP) Expert 
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in 
Adults (Adult Treatment Panel or ATP III) recommends primary prevention in 
persons with multiple risk factors (cigarette smoking, hypertension, low HDL 
cholesterol « 40 mgjdL), family history of premature CHD (CHD in male first 
degree relative < 55 years; CHD in female first degree relative < 65 years), age 
(male ~ 45 years and female ~ 55 years), and diabetes. ATP III defined the 
optimal values of a fasting lipoprotein profile as follows: total cholesterol <200 
mgjdL; LDL cholesterol <100 mgjdL; HDL cholesterol between 40 and 60 mgjdL 
in males and between 50 and 60 mg/dL in females; and triglycerides <150 
mgjdL. According to ATP III, persons with 3 of the metabolic risk factors 
(metabolic syndrome) are candidates for intensive therapeutic lifestyle changes 
(NCEP, 2001). 
One of important component of intensive therapeutic lifestyle change is 
diet. Reduction of saturated fats « 7% of total calories) and cholesterol «200 
mgjday) intakes along with a well balanced diet (total fat 25 to 35% of total 
calories, carbohydrate 50 to GO%, protein 15%) with increased fiber (20 to 30 
gjday) is effective in controlling lipid profiles and reducing the risk of CHD and 
other metabolic disorders. A balanced energy intake and expenditure to 
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maintain desirable body weight, prevent weight gain or reduce weight by 
increased physical activity is also essential (NCEP, 2001). 
serum C-Peptide and serum Insulin 
Pancreatic J3-cells secrete C-peptide with insulin. Both fasting insulin and 
C-peptide levels reflect the degree of insulin production (Laakso, 1993; Chen et 
aI., 1999). Olesky (1981) reported that fasting insulin levels are reliable markers 
of insulin resistance and have been used as a reasonable method for determining 
insulin resistance in a population study. 
However, several authors reported that C-peptide is a more accurate 
measure of insulin production than fasting insulin. A high C-peptide 
concentration indicates elevated J3-cell production of insulin (Haban et ai, 2002), 
while an elevated insulin concentration may be caused by both excess J3-cell 
production and reduced hepatic clearance (Giugliano et al., 1993). serum C­
peptide is not extracted by the liver, so it better reflects true pancreatic secretion 
of insulin. In addition, plasma C-peptide, unlike serum insulin, is unaffected by 
hemolysis (O'Rahilly et aL, 1987). According to Chen et al. (1999), serum C­
peptide is a better indicator of metabolic syndrome than serum insulin, because 
serum C-peptide had greater correlation with the recognized markers of 
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metabolic syndrome independent of insulin. They also found significant 
interactions of sex and 8MI for serum C-peptide, but not for serum insulin. 
Haban et al. (2002) also reported that serum C-peptide levels constitute a 
clinically important marker of the cardiovascular risks associated with clusters of 
known risk factors of metabolic syndrome. 
Harris et al. (2002) examined the racial-ethnic differences in fasting insulin 
and C-peptide concentrations in adults with no prior history of diabetes. They 
found that non-Hispanic blacks exhibited lower C-peptide values (640.5±12.7 
pmol/L) than whites (696.8±9.3 pmol/l) and Mexican Americans (750.5±11.0 
pmol/L). The results also showed that non-Hispanic blacks (68.5±1.6 pmol/L) 
had higher insulin concentrations than whites (59.6±1.6 pmol/L) but not Mexican 
Americans (70.8±1.4 pmol/L). The study results implied that African Americans' 
hyperinsulinemia is explained by impaired J3-cell function and impaired insulin 
clearance (probably due to reduced hepatic extraction) in the basal state, despite 
their peripheral tissue insulin resistance. Thus, using both serum insulin and 
serum C-peptide helps us understand the pathophysiologic background (portal 
, 
versus peripheral) of insulin resistance. 
Effects of Dietary Intake 
Improving insulin sensitiVity and correcting/preventing the associated 
metabolic and cardiovascular abnormalities (hypertension, type 2 diabetes, and 
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dyslipidemia: high triglyceride; low HDl-cholesterol and smaller & denser lDl 
particles) that are linked with insulin resistance are critical for treatment and 
prevention of metabolic syndrome (Riccardi et aI., 2000). Since most of the 
individuals affected by the metabolic syndrome are overweight, particularly with 
central obesity (Everson et aL, 1998), dietary treatment focused on weight 
reduction with increased physical activities is beneficial and important (Torjesen 
et al., 1997). 
Dietary patterns of individuals are influenced by various aspects, such as 
cultural and ethnic ba.ckground, religious and philosophical belief, psychosocial 
(depression, substance abuse) and sociodemographic (food availability) factors. 
Changes in nutritional habits by modifications of food intake (quality and quantity) 
are a foremost challenge (Dickey, et aL, 1998). Major lifestyle changes 
accompanied with weight reducing strategies, such as low-calorie diet, low-fat 
diet, and regular aerobic exercise, are challenging and hard to adopt and sustain 
(Costa et aL, 2000; Hara et aI., 1996; Krentz, 1996). 
An Expert Panel of the National Heart, Lung, and Blood Institute (NHLBI) 
Obesi.ty Education Initiative reported that lower-fat diets with targeted caloric 
reduction promote greater weight loss than lower-fats diets alone. Reducing 
dietary carbohydrates along with dietary fat can further facilitate calorie 
reduction. Physical activity is also recommended as an integral part of weight 
loss therapy and weight maintenance (Pi-Sunyeret aL, 1998). The American 
Association of Clinical Endocrinologists/American College of Endocrinology 
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(MCEtACE) Obesity Task Force emphasized the importance of weight loss 
maintenance, because it requires a lifelong commitment to a change in lifestyle, 
behavioral responses, and dietary practices (Dickey et al., 1998). 
Maintaining weight loss seems to be more difficult than losing weight, 
particularly for patients who are treated with caloric restriction. Simple 
instructions are not sufficient for behavioral changes. Long-term lifestyle 
changes are necessary to achieve lasting health improvements (Costa et aI., 
2000; Hara et aL, 1996; Krentz, 1996). 
Protein has greater thermogenic and satiating effects than does 
carbohydrate, which may be relevant for the prevention and treatment of obesity 
if these effects can be maintained over 24 hours (Mikkelsen et aL, 2000). 
Mikkelsen et al. (2000) conducted a randomized, single-blind, 3-way crossover 
study lasting four days (With a 1-10 week washout period) on twelve young, 
healthy, overweight and mildly obese (8MI: 26-32) nonsmoking men. The 
effects of three isoenergetic intervention diets as follows: pork diet (290/0 of 
energy as fat and 29% as protein, mainly from pork meat), soy diet (29% of 
energy as fat and 280/0 as protein, mainly from soy) , and carbohydrate diet 
(280/0 of energy as fat and 110/0 as protein) were compared. 24-hour energy 
expenditure was measured in a respiratory chamber at baseline and on day 4 of 
each intervention period. Daily energy expenditure was 20/0 higher with the pork 
than with the soy or carbohydrate diet. In addition, energy intake was 10-150/0­
lower on pork diet, due to a higher satiating effect. According to Skov et aL 
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(1999), reduced fat diets with protein substituted for carbohydrate showed 
greater improvements in weight loss. However, a high dietary protein intake is 
often accompani'ed by increased saturated: fat and cholesterol intakes. Thus, 
application of these findings to public dietary advice should be done cautiously 
(Hu et aL, 1999; Marshall et aL, 1997; Elmstahl et aL, 1999). 
As demonstrated in the Insulin Resistance Atherosclerosis Study, the 
relationship between dietary factors and insulin sensitivity is complex and 
controversial. In obese subjects with a sedentary lifestyle, a high intake of 
dietary fats (40% of total energy) was associated with worsened insulin 
sensitivity, but not in non-obese subjects (Mayer-Davis et aI., 1997; Hauner, 
2002). Glucose and lipid metabolism were strongly related. A high saturated fat 
intake (16% of total energy) was linked with glucose intolerance and other 
metabolic disturbances such as elevated total and LDL-cholesterol. On the other 
hand, low-fat, high-carbohydrate diets reduce LDL concentrations when 
saturated or trans fats are replaced with carbohydrates, but these diets are also 
associated with an elevation of fasting triglycerides and a decrease in HDL­
, 
cholesterol in both normal individuals and subjects with type 2 diabetes (Hauner, 
2002; Reaven, 1997; Hu et aL, 1999; Mensink et aI., 1992; Elmstahl et aI., 1999). 
Several researchers examined the association between fatty acid 
composition in serum and insulin sensitivity. A high insulin sensitivity in humans 
was associated with low proportions of palmitic acids (16:0) and palmitoleic acids 
(16:1 n-7), and high proportion of inoleic acids (18:2 n-6), which are mainly 
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found in plant foods. The proportions of y-Iinolenic acids (18:3 n-6) and dihomo­
y-Iinolenic acids (20:3 n-6), which are metabolites of linoleic acid in the insulin 
sensitive subjects, were low. The changes in the fatty acid pattern among 
insulin resistant or diabetic subjects indicated that they may have had an al:tered 
dietary fat composition, compared to healthy peopl'e (Hauner, 2002; Vessby, 
2000). Increased intake of saturated fat, monounsaturated fat and linolenic 
acids appeared to be associated with hyperinsulinemia, while polyunsaturated 
fatty acids and linoleic acid were not (Marshall et aI., 1997). Replacing saturated 
fat with monounsaturated or polyunsaturated fat, or both, has some metabolic 
benefits along with a fall in LDL-cholesterol. A high monounsaturated fat diet 
significantly improved insulin sensitivity compared to a high-saturated-fat diet. 
However this beneficial effect of monounsaturated fat disappeared in individuals 
whose total fat intake exceeded 38% of total energy (Hauner, 2002; Vessbyet 
aI., 1999). A reduction of fat intake (monounsaturated fat) counterbalanced by 
an increased consumption of starchy foods was also reported to slightly worsen 
insulin sensitivi.ty (Garg et aI., 1988 & 1994; Coulston et aI., 1987 & 1989). In 
, 
short, many features of the metabolic syndrome are worsened by increasing 
dietary carbohydrate (Riccardi et al., 2000). Hauner (2002) suggests that it is 
the quality rather than the total amount of fat that really matters. 
Based on physiologic, epidemiol'ogic, and clinical eVidence, the low-fat, 
high-carbohydrate diet is not appropriate for the insulin resistant and/or 
hyperinsulinemic patient. In the insulin resistant patient, a high-carbohydrate 
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diet produces a greater insulin response to glucose and plasma insulin level 
(Hollenbeck et aL, 1991). A high-earbohydrate diet may not improve insulin 
sensitivity and has potentially unfavorable effects on lipoprotein metabolism 
(Garg et al., 1994; Reaven, 1997). For patients with diabetes, high-carbohydrate 
diets may contribute to deterioration of glycemic control, accentuation of 
hyperinsulinemia, and increased plasma VLDL-cholesterol and triglycerides levels 
(Wangerin-Ule et aL, 2000; Garg et al., 1994; Reaven, 1997). 
Some researchers suggest that the most appropriate diet for insulin 
resistant/hyperinsulinemic individuals is adequate (not high) protein, moderate 
complex carbohydrate, minimal amounts of refined carbohydrate, and healthy fat, 
such as monounsaturated fatty acids. According to Wangerin-Ule et aL (2000), 
this type of diet could be readily integrated into the lifestyle of patients with 
insulin resistance or type 2 diabetes with clinically significant Improvements in 
fasting insulin levels, HbA1c, triglycerides, and triglycerides/HDL-cholesterol ratio. 
A high intake of low glycemic index foods, such as foods containing soluble fibers, 
was not only associated with an improvement in insulin sensitivity, but also an 
improvement in other disturbances characteristic of the metabolic syndrome 
(Hauner, 2002; Jenkins et aL, 2000). 
Several studies investigated the relationship between dietary protein 
intake and lipid profiles and the risk of related metabolic disorders. Exchange of 
animal protein for carbohydrates in human diets significantly reduced LDL­
cholesterol and triacylglyceride concentrations and increased HDL-cholesterol 
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However, the consumption of very lean meats as part of low fat diets has 
resulted in reduced blood lipid concentrations (Davidson et aI., 1999). SCott et al. 
(1994) examined the comparability of lean beef and chicken in a Step I diet (8 
to 10% of energy intake from saturated fatty acids) and concluded that lean beef 
and chicken were interchangeable in the Step I Diet, since they had similar 
effects on plasma levels of total cholesterol, LOL-cholesterol, HOt-cholesterol 
and triglyceride. Bales et al. (1995) found that very lean red meats such as lean 
pork, with a fat content 35 to 61% lower than traditional pork, can be used as 
successfully as chicken in reduced-fat diets which contain substantial amounts of 
meat. A total of 51 subjects were randomly assigned to either a skinless chicken 
or lean pork diet, both providing 25% of calories as fat (calorie levels were 
adjusted to avoid weight loss or gain) for 28 days. serum lipids were measured 
at baseline and the end of the study. Both diets reduced total cholesterol and 
LOL cholesterol. HDl cholesterol was reduced in the skinless chicken group, but 
not in lean pork group. The incorporation of lean red meats can thus be used to 
enhance dietary variety and nutritional completeness for individuals seeking to 
improve their blood lipids. 
Therefore, animal protein from lean meat should be recommended for 
prevention and treatment of insulin resistance and metabolic syndrome. Foods 
containing animal protein are consumed by most adults in the US population. 
Eating more protein may enhance the successful compliance to diet therapy for 
insulin resistance by improving glycemic control without elevating lipid levels. 
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CHAPTER III 
METHODOLOG,y 
The objective of this study was to examine the relationship of protein 
intake with lipoprotein profiles (total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides) and glycemic profiles (fasting and postprandial glucose 
and insulin, C-peptide, and hemoglobin Ale) in people who are at risk of insulin 
resistance. This study analyzed data. from the Third National Health and 
Nutrition Examination Survey (NHANES III). 
Study population and Design 
The National Center for Health Statistics (NCHS) of the Centers for 
Disease Control conducted a cross-sectional survey, NHANES III from 1988 
through 1994 (NCHS 1994). NHANES III was designed to proVide nationally 
representative reference data and prevalence estimates for numerous nutrition, 
health status, and health condition measures. Complex, stratified, multistage 
probability cluster sampling was used to select a representative sample of the 
civilian noninstitutionalized population of the United States aged 2 months and 
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older. NHANES III oversampled Mexican-Americans, African-Americans, children 
aged 2 months to 5 years old, and adults aged 60 years and older to provide 
representative data from these population subgroups. Socioeconomic, 
demographic, health behavior, lifestyle, personal and family health, and food 
frequency data were collected via extensive questionnaires administered at home 
by health interviewers to 33,994 participants from 19,528 househords throughout 
the United States. 
Additional health, 24-hour dietary recall and laboratory data were 
collected from 30,818 of the participants by health professionals during visits to 
NHANES mobile examination centers (MEC) at 89 sites. Participants who were 
unable for health reasons or unwilling to attend the examination centers were 
offered a limited home examination. The survey procedures were approved by 
the NCHS Internal Review Board, and all participants signed informed consent 
forms. Details of the plan and operation of NHANES III and laboratory 
procedures used for the NHANES III have been published (NCHS 1994). 
Study sample 
For this study, we selected participants who met at least one of the 
identified criteria (Table 1). According to literature adults who are obese, have a 
family history of diabetes mellitus, high waist circumference, impaired fasting 
glucose, or mildly elevated triglycerides are at high risk of being insulin resistant. 
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We selected obese males with a body mass index >27.8 kg/m2 or waist 
circumference >102cm; and obese females with a body mass index >27.3 
kg/m2 or waist circumference >97cm. (Dickey et aI., 1998) We used the blood 
glucose concentrations above 6.1 mmol/L as an indicator of impaired fasting 
glucose according to the American Diabetes Association criteria (Unwin N et aI., 
1998). serum triglycerides concentrations between 150 and 499 mg/dL were 
selected as mildly elevated according to National Cholesterol Education 
Program's Adult Treatment Panel III (NCEP, 2001). We excluded adults who 
reported being told they had diabetes, took insulin or oral hypoglycemic agents 
or had high serum triglycerides concentrations (>500mg/dL). 
The initial sample for our analyses included 14788 people. From this 
initial sample, we excluded 240 participants who had no food frequency data. 
We excluded an additional 754 participants whose 24-hour dietary recalls were 
not reliable and complete. The final sample size for analysis included 13794 
adults (7245 women and 6549 men). 
Measurement of Diet 
Dietary data were collected using two instruments: a single 24-hour 
dietary recall and a 1-month qualitative 60-item food frequency questionnaire 
(FFQ). In NHANES In, 24-hour dietary recalls were used as the principal 
methodology to obtain quantitative information on food and nutrient intakes of 
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the US population. Nutrient intakes for each participant were calculated using 
the gram amounts of the food consumed. The USDA Survey Nutrient Database 
and The University of Minnesota Nutrition Coordinating center nutrient database 
were used for the dietary nutrient intake analysis. Results in this study are 
reported for nutrient data analyzed using the University of Minnesota database. 
The 24-hour dietary recall was administered at theMEC using an 
automated, interactive interview and coding system that featured a standardized 
interview format and automated probes to obtain detailed information about all 
foods and beverages consumed the previous day, including brand names, food 
preparation methods and ingredients used tn food preparation methods (NCHS 
1994). Portion sizes were quantified using abstract food models, shape charts 
and measuring aids such as rulers, cups, and spoons.. seasoning added to 
prepared foods at the table, nutrients from dietary supplements and medications 
were not included. Each individual's intake of energy, fat, fiber, protein, vitamins 
and minerals was estimated from their 24-hour dietary recall. Dietary recalls 
were collected on every day of the week; weekend days are underrepresented, 
whereas Fridays are overrepresented. For further details of these procedures 
see the description by Briefel et al. (1997). 
The FFQ was administered during the household interview and asked the 
average number of times foods were eaten dUring the 1-month period preceding 
the respondent's interview date. Frequencies of specific types of foods from the 
following designated food groups and subgroups were ascertained: milk and milk 
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products, meat and meat dishes, eggs and egg dishes, fruits and fruit juices 
(including citrus fruits and fruit juices), vegetables (including dark green leafy 
vegetables, deep orange and yellow vegetables and white potatoes), grains and 
legumes (including cereals, breads, legumes and salty snacks), desserts and 
sweets, beverages (including nonalcoholic and alcoholic beverages) and added 
fats. The NHANES III FFQ did not include information about portion size and 
cannot be used to estimate nutrient intakes. However, this method of dietary 
assessment is appropriate for comparing frequencies of food intakes between 
groups of individuals (11lompson et aI., 1994). 
Protein intake was estimated by 24-hour dietary recal:l data. Participants 
were divided into quartiles by two classification methods: grams of total dietary 
protein and grams of animal protein from the 24-hour recall (see Table 2). 
Measurement of Lipid and Glycemic Profiles 
Blood was collected from participants in the MEC through venipuncture 
using standard protocols. Several blood components were analyzed for NHANES 
III. Concentrations of serum cholesterol, serum triglycerides, serum HDL 
cholesterol, serum glucose, serum C-peptide, serum insulin, plasma glucose, and 
glycated hemoglobin were measured in this study. All participants were 
instructed to fast at least 8.5 hours if examined in the morning or at least 6 
hours if examined in the afternoon (NCHS 1994). The following assay 
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methods/instrumentations were used: for serum glucose, Hitachi 737 Analyzer 
(Thermo Trace Automated Colorimetric Lithium test)/Boehringer-Mannheim 
Diagnostics; for plasma glucose, Hexokinase System/Roche COBAS MIRA Chern 
System; for serum cholesterol and triglycerides, Hitachi 704 Analyzer (Thermo 
Trace Automated Colorimetric Lithium test)/Boehringer-Mannheim Diagnostics; 
for serum insulin, Insulin Radioimmunoassay Kit/Pharmacia Diagnostics; for C­
peptide, Radioimmunoassay/Novo BioLabs; and for Glycated hemoglobin, 
DIAMAT high-pressure liquid chromatographyjBio-Rad Laboratories. Values for 
serum LDl cholesterol were calculated by the Friedewald equation (Friedewald et 
aI., 1972). 
Blood samples for NHANES III were collected at the MEC and analyzed by 
the designated laboratories. Detailed information about the procedures and 
quality control protocols used for the measurement of these serum lipid and 
glycemic profiles are provided in the NHANES III documentation (NCHS 1994, 
1996) and in the Laboratory Procedures used for NHANES III (Gunter et al. 
1990). 
Measurement of Covariates 
Dietary and biochemical data vary by sociodemographic and behavioral 
characteristics. To determine whether protein intake was independently 
associated with differences in lipoproteins or indicators of glycemic control, we 
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adjusted for several potentially confounding variables in our analyses. 5elf­
reported gender and age were collected dUring the household interview. Other 
confounding variables included clinically measured BMI (kg/m2); waist 
circumference; dietary fat and carbohydrate intake; and the number of risk 
factors (Table 1: inclusion criteria). All body measurements were taken using 
standard anthropometric protocols (NCHS, 1988). 
Behaviors, including alcohol consumption and leisure-time physical 
activities were determined from questions asked during the household interview 
or at the MEC. Alcohol consumption was estimated from the 1-month FFQ. We 
summed the total number of alcohol drinks (beer, wine, and hard liquor) 
consumed in the past month to estimate alcohol consumption. Respondents 
were also asked about SPeCific leisure-time physical activities (walking, 
jogging/running, bicycling, swimming, aerobics/dancing, calisthenics, gardening, 
and lifting weights) and their frequency and intensity during the past month. We 
estimated metabolic equivalents (METs) by multiplying frequency by intensity 
(see Table 3) and summing all measures of energy expenditure reported by each 
, 
respondent in the past month. 
Statistical Analysis 
First, we compared histograms of data to the normal curve. Biochemical 
data were not normally distributed. In order to improve normality of data, we 
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used.sess to convert BMI, biochemical, and dietary variables to a log scale. 
Total protein and animal protein quartiles were calculated. 
We used SUDAAN (release 7.5.6, 2000, Research Triangle Institute, 
Research Triangle Park, NC), a computer program that takes into account the 
complex, stratified, multistage survey design and sample weights of NHANES III 
(Shah et al., 1997) to analyze the data. The association between protein intake 
and lipid and glycemic profiles for crude values and adjusted values were tested 
with analysis of variance and analysis of covariance followed by the SCheffe's 
multiple comparisons test to determine differences between quartiles of protein 
intake. To adjust for their known confounding effects, age, sex, BMI, waist 
circumference, lifestyle factors (physical activity and alcohol consumption), 
dietary intake (fat and carbohydrate), and number of risk factors were entered 
into the analysis as covariates. Pearson correlation coefficients were calculated 
to determine bivariate relationships between giycemic and lipid profires and age, 
sex, race-ethnicity, BMI, waist circumference, physical activity, dietary intake 
(protein, total fat, total saturated fatty acids, cholesterol, carbohydrate, and total: 
dietary fiber), family history, and number of risk factors. P values of <0.05 
indicated statistical significance. 
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Research HyDOtheses 
Hypothesis One 
(a) Null Hypothesis - Glycemic profiles (glucose, insulin, C-peptide, and 
hemoglobin Alc) are not associated with quartiles of total and animal protein 
intake in adults at risk of i'nsulin resistance 
(b) Research Hypothesis - Glycemic profiles are associated with quartiles of total 
and animal protein intake in adults at risk of insulin resistance 
(c) Sub Hypothesis - Glycemic profiles are positively associated with quartiles of 
total and animal protein intake in adults at risk of insulin resistance 
(d). Sub Hypothesis - Glycemic profiles are negatively associated with protein 
intake in adults at risk of insulin resistance 
Statistical analysis Analyses of covariance were used to determine the 
relationship between glycemic profiles and protein intake in adults at risk of 
insulin resistance after adjusting for sex, age, 8MI, waist circumference, physical 
actiVity, fat, carbohydrate, and alcohol tntake, and number of risk factors. 
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Hypothesis Two 
(a) Null Hypothesis - Lipoprotein profiles (total cholesterol, LDL cholesterol, HDL 
cholesterol, triglycerides) are not associated with quartiles of total and animal 
protein intake in adults at risk of insulin resistance 
(b) Research Hypothesis - Lipoprotein profiles are associated with quartiles of 
total and animal protein intake in adults at risk of insulin resistance 
(c) Sub Hypothesis - Upoprotein profiles are positively associated with quartiles 
of total and animal protein intake in adults at risk of insulin resistance 
Statistical analysis Analyses of covariance were used to determine the 
relationship between lipoprotein profiles and protein intake in adults at risk of 
insulin resistance after adjusting for sex, age, BMI, waist circumference, physical 
activity, fat, carbohydrate, and alcohol intake, and number of risk factors. 
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Table 1 Inclusion and Exclusion Criteria 
Inclusion Criteria Value Indicating Risk 
Body Mass Index ef': >27.8; ~: > 27.3 
(kg/m 2) 
Waist Circumference	 ef': > l02cm; ~: >97cm 
Family History	 Type 2 Diabetes 
Mellitus 
Blood Glucose >6.1 
(mmoI/L) 
Serum Triglycerides 150 to 499mg/dL 
(mgldL) 
I 
Exclusion Criteria Value Indicating Risk 
Diabetes Mellitus	 Reported diagnosis of 
Diabetes Mellitus, or 
taking insulin or oral 
hypoglycemic agents 
Severely Elevated >SOOmgjdL 
Serum Triglycerides 
(mgjdL) 
Source of Value 
Dickey RA, Bray GA, Bartuska DG, et al. 
MCE/ACE position statement on the 
prevention, diagnosis, and treatment of 
obesity. Endocrine Praeuce. 1998;4:297­
330. 
Dickey RA, Bray GA, Bartuska DG, et al. 
MCE/ACE position statement on the 
prevention, diagnosis, and treatment of 
obesity. Endocrine Pradice. 1998;4:297­
330. 
Wangerin-Lile 0, Gear Sl. Insulin resistance 
and hyperinsulinemia: recognizing the risk 
and reversing the process. Physician 
Assistant 2000:24:23-31. 
Unwin N, Alberti KGMM, Bhopal R, et al. 
Comparison of the current WHO and new 
ADA criteria for the diagnosis of diabetes 
mellitus in three ethnic groups in the UK. 
Diabetic Medicine 1998;15:554-557. 
Third report of the National Cholesterol 
Education program (NCEP) Expert Panel on 
detection, evaluation, and treatment of high 
blood cholesterol in Adults (Adult Treatment 
Panel III) 
Source of Value 
Unwin N, Alberti KGMM, Bhopal R, et al. 
Comparison of the current WHO and new 
ADA criteria for the diagnosis of diabetes 
mellitus in three ethnic groups in the UK. 
Diabetic Medicine 1998;15:554-557. 
Peters AL, Davidson MB, 5chriger DL, 
Hasselblad V. A dinical approach for the 
diagnosis of diabetes mellitus. lAMA. 
1996;276:1246-1252. 
Feskens EJM, Stengard ], Virtanen SM, et 
al. Dietary factors determining diabetes and 
impaired glucose tolerance. Diabetes Care. 
1995'18: 1104-1112. 
Third report of the National Cholesterol 
Education program (NCEP) Expert Panel on 
detection, evaluation, and treatment of high 
blood cholesterol in Adults (Adult Treatment 
Panel lIn 
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Table 2 Total protein and animal protein intake by quartiles 
<25 lS:.5Q 50-75 >75 
Variables Mean S.E. Mean S.E. Mean S.E. Mean S.E. 
Total Protein (gm) 36.01 0.21 60.08 0.13 83.70 0.19 139.10 1.35 
Male 38.20 0.58 60.81 0.22 84.69 0.28 143.42 1.59 
Female 35.33 0.25 59.65 0.16 82.69 0.28 125.43 1.45 
Animal Protein (gm) 19.27' 0.14 38,03 0.10 57.02 0.18 103.71 1.00 
~ 
0 
Male 20.41 0.39 38.68 0.17 57.69 0.28 107.66 1.25 
Female 18.83 0.14 37.60 0.14 56.38 0.26 93.03 1.23 
Table 3 Metabolic equivalents provided by various phsical activities (adapted from Physical Activity and Health: 
A Report of the Surgeon General, 1996) 
Intensity 
Moderate 
Moderate 
Moderate 
Moderate 
~ Moderate 
...... 
Moderate 
Hard 
Hard 
Very hard 
Activity METs1 
Volleyball, noncompetitive 3.0 
Walking, moderate pace (3 mph, 20 min/mile) 3.5 
Walking, brisk pace (4 mph, 15 min/mile) 4.0 
Table tennis 4.0 
Social dancing 4.5 
Lawn mowing (powered push mower) 4.5 
Jogging (5 mph, 12 min/mile) 7.0 
Field hockey 8.0 
Running (6 mph, 10 min/mile) 10.0 
lMtTs=Metabolic eqUivalents 
CHAPTER IV 
RESULTS 
The objective of this study was to examine the relationship of protein 
intake with lipoprotein and glycemic profiles in adults who were at risk of insulin 
resistance. Data were obtained from NHANES III (1988-1994) conducted by 
NCHS as described in chapter III. 
sample Size and Characteristics 
NHANES III (1988-1994) data were obtained from 33,994 participants 
from 19,528 households throughout the United States. This study included 
13,794 people (7254 women and 6549 men) who had at least one risk factor for 
insulin resistance (Table 1) after excluding adults who had been diagnosed with 
diabetes, reported taking insulin or oral hypoglycemic agents, or had very high 
triglyceride concentrations. The average number of risk factors per participant 
was 1.7. 
Risk of insulin resistance was assessed by BMI, waist circumference, 
serum triglycerides, blood glucose or family history of diabetes (Tabte 4 and 5, 
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Figures 1 and 2). About half the adults exhibited only one risk factor and about 
400/0 exhibited two risk factors. Few people (2.2%) exhibited more than four risk 
factors. A high BMI was most common risk factor (71.3%) for both men and 
women. Family history was the second most common risk factor for women, 
whereas serum triglycerides was the second risk factor for men. 
Table 6 lists the demographic characteristics of the sample population. 
Participants ages ranged from 17 to 90 years old. The average age of 
participants was 43 years. The average 8MI of participants was 26 kg/m2 and 
the average waist circumference was 90 em. Participants reported average total 
METs of 16 (with 0 indicating no leisure time physical activity and 10 indicating 
one very hard intensity activity such as running at 6 mph once during the month) 
(see Table 3) and an alcohol consumption of 9 drinks per month. The average, 
dietary intake of participants (0/0 of total energy) was: total fat 35.5%; protein 
14.90/0; animal protein 10.1%; and carbohydrate 49.7%. Average protein intake 
based on 24 hour recalls in this sample was 79.4 ± 44.7 gm/day (1.3 g/Kg). 
When assessed separately by gender, the average age of women was 
slightly higher than men's age and men had larger waist circumferences than 
women, though physical activity (total METs) reported by both genders were 
similar (Table 7). Men consumed about twice as much alcohol per month as 
women. Men consumed more fat, total protein, animal protein, carbohydrate, 
and alcohol than women, although intake was similar when expressed as percent 
of total energy intake: total fat, male 35.9%, female 34.70/0; protein, male 
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15.10/0, female, 14.7%; animal protein, male 10.5%, female 9.9%; and 
carbohydrate, male 48.9%, female 50.6%. 
Lipid and Glycemic Profiles 
Tables 8 & 8A present the average lipid and glycemic values for adults at 
risk for insulin resistance. Referring to Adult Treatment Panel III (NCEP 2001) 
and the American Diabetes Association criteria (Unwin et aI., 1998), the average 
total cholesterol concentrations were borderline high and LDL cholesterol were 
near optimal/above optimal. Average HDL cholesterol, triglycerides, and 
glycemic values were within the normal range. Average values were similar for 
both genders (Table 9 & 9A). Women had slightly higher HDL cholesterol than 
men. Men exhibited slightly higher triglycerides than women. 
Lipid and Glycemic Profiles and Descriptive Variables 
Table 10 presents the Pearson's correlation coefficients between lipid and 
glycemic profiles and descriptive variables. sex, age, BMI, waist circumference, 
and number of risk factors were correlated significantly with all lipid and glycemic 
profiles. Physical actiVity was correlated only with HDL cholesterol. sex (l=male, 
2=femal'e) was negatively correlated with LDL cholesterol, triglycerides, serum 
glucose, plasma glucose, and glycated hemoglobin, indicating that females had 
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lower concentrations for these measures. Age was strongly positively correlated 
with all lipid and glycemic profiles, except HDL cholesterol which was weakly 
correlated with age. Other strong positive correlations were observed between 
8MI, waist circumference, and number of risk factors and lipid and glycemic 
profiles (except HDL which was negatively correlated with BMI and waist 
circumference). 
Lipid and Glycemic Profiles and Dietary Variables 
Table 11 presents the correlations between lipid and glycemic profiles and 
dietary variables. Macronutrient intakes were weakly correlated with lipid and 
glycemic laboratory values. Total protein intake was negatively correlated with 
total cholesterol, HDL cholesterol, and glycated hemoglobin. Animal protein 
intake was negatively correlated with total cholesterol and HDt cholesterol. Fat 
intake was negatively correlated with total cholesterol, HDL cholesterol, 
triglycerides, plasma glucose, and glycated hemoglobin. saturated fat intake 
was negatively correlated with total cholesterol, HDL cholesterol, and glycated 
hemoglobin. Carbohydrate intake was negatively correlated with all lipid and 
glycemic profiles except serum glucose, plasma glucose, and serum insulin. 
Dietary fiber was positively correlated with triglycerides and serum glucose, and 
negatively correlated with HDt cholesterol, serum insulin, and serum C-peptide. 
HDt cholesterol was negatively correlated with all dietary variables. 
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Lipid and' Glycemic Profiles by Protein Quartiles 
Tables 12 & 12A and 13 & 13A present the association between lipid and 
glycemic profiles and total and animal protein ;intake by quartiles. When 
adjusted for age, sex, 8MI, waist circumference, life style factors (physical 
activity and alcohol consumption), dietary factors (fat and carbohydrate intake), 
and number of risk factors, total cholesterol, HDL cholesterol, serum insulin, and 
serum C-peptide were significantly different by total protein quartile (p<O.05) 
and total cholesterol, HDL cholesterol, and serum insulin were significantly 
different by animal protein quartile (p<O.05). For both total cholesterol and HDL 
cholesterol, average values were higher in the lowest protein quartile compared 
to the highest protein quartile. However, serum insulin was lowest in the second 
quartile of both total and animal protein and serum c-peptide was lower in the 
second and highest quartiles of total protein. 
Table 14 & 14A presents the association between lipid and glycemic 
profiles and total protein quartiles by gender. When adjusted for age, 8MI, waist 
circumference, lifestyle factors (physical activity and alcohol consumption), 
dietary factors (fat and carbohydrate intake), and number of risk factors, total 
cholesterol for men and serum C-peptide for women exhibited significant 
differences by total protein quartiles (p<O.OS). Males in the second highest total 
protein quartile (3rd quartile) exhibited slightly higher total cholesterol levels than 
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other quartiles (P<O.04). Although overall statistical significance was exhibited, 
no quartile differences were observed in serum C-peptide levels of femare by 
total protein quartifes. 
Table 15 & 15A presents the association between lipid and glycemic 
profiles and animal protein quartiles by gender. When adjusted for age, BMI, 
waist circumference, lifestyle factors (physical activity and alcohol consumption), 
dietary factors (fat and carbohydrate intake), and number of risk factors, total 
cholesterol for both men and women, and serum insulin for men were 
significantly different (p<O.05). As exhibited in total and animal protein quartiles, 
men in second highest total protein quartile (3rd quartile) had slightly higher total 
cholesterol levels than men in other quartil.es. Women in the lowest quarti:le (1st 
quartile) and the highest quartile (4th quartile) as well as the second highest 
quartile (3 rd quartile) exhibited differences in total protein .. Also women in the 
second lowest quartile (2nd quartile) and the highest quartile (4th quartile) 
exhibited differences. Notably, total cholesterol levels decreased as animal 
protein intake increased from lowest to highest in women. Men in the second 
lowest animal protein quartiles (2nd quartile) exhibited slightly lower serum 
insulin levels than the rest of the quartiles. 
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Table 4 Number of risk factors for insulin resistance exhibited by 
people who have valid food intake record 
Number of Risk Factor No.1 0/0 
1 6287 47.6 
2 5301 38.0 
3 1855 12.2 
4 335 2.1 
5 16 0.1 
1No.=unweighted sample size 
Table 5 Percentage of people who exhibited specific risk factors for 
insulin resistance 
0/0 
Body Mass Index 71.3 
Waist Circumference 28.0 
Family History 33.1 
Blood Glucose 7.1 
serum Triglycerides 29.6 
Serum Triglycerides 
Blood Glucose 
Family History 
Waist Circumference 
o 10 20 30 50 60 70 80
 
o~ or adults 
Figure 1. Proportion of males It females who exhibited risk factors for 
insulin resistance 
5
 
o 5 10 15 20 25 30 35 40 45 50
 
Figure 2. Proportion of subjects who exhibited different numbers of 
risk factors for insulin resistance 
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Table 6 Characteristics and Dietary Intake of the Study Population 
Characteristics 
Age (Years) 
Body Mass Index (kgjm2) 
Waist Circumference (em) 
Physical Activity SCore (METs2) 
Total Fat Intake (gm) 
Protein Intake (gm) 
Animal Protein Intake (gm) 
Carbohydrate Intake (gm) 
Alcohol (drinksjmonth) 
Risk Factor (no.) 
INo.=unweighted sample size 
2METs=metabolic equivalents 
No.1 
13794 
13773 
13269 
13794 
13794 
13794 
13794 
13794 
13790 
13794 
Mean S.E. 
42.58 0.11 
25.85 0.13 
90.45 0.24 
15.85 2.14 
86.88 0.92 
82.45 0.71 
56.42 0.60 
273.59 2.05 
8.75 0.29 
1.69 0.01 
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Table 7 Characteristics and Dietary Intake of the Study Population by 
Gender 
Characteristics No.1 
Age (Years) 6549 
Body Mass Index (kg/m2) 6543 
Waist Circumference (em) 
Physical Activity Score 
(METs2) 
6324 
6549 
Total Fat Intake (gm) 6549 
Total Protein Intake (gm) 6549 
Animal Protein Intake (gm) 6549 
carbohydrate Intake (gm) 6549 
Alcohol (drinks/month) 6548 
Risk Factors (no.) 6549 
INo.=unweighted sample size 
2METs=metabolic equivalents 
Male
 
Mean
 
41.67 
26.19 
93.91 
19.87 
105.93 
100.39 
69.54 
324.30 
12.51 
1.72 
S.E. 
0.15 
0.10 
0.25 
3.97 
1.59 
1.11 
0.92 
3.24 
0.46 
0.02 
Female 
No. 1 Mean S.E. 
7245 43.43 0.14 
7230 25.85 0.13 
6945 87.23 0.33 
7245 12.13 1.11 
7245 69.16 0.70 
7245 65.77 0.66 
7245 44.23 0.55 
7245 226.43 1.89 
7242 5.26 0.28 
7245 1.66 0.01 
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Table 8 Average lipid and glycemic values for adults at risk for insulin 
resistance 
Total Cholesterol (mg/dl) 
LDL Cholesterol (mg/dL) 
HDL Cholesterol (mg/dl) 
Triglycerides (mg/dl) 
serum Glucose (mg/dL) 
Plasma Glucose (mg/dL) 
serum Insulin (uU/mL) 
serum C-peptide (pmol/mL) 
Glycated Hemoglobin (0/0) 
1No.=unweighted sample size 
No.1 
13793 
13764 
13765 
13794 
13792 
12819 
12784 
12825 
13728 
Mean S.E. 
200.99 0.70 
123.98 0.62 
51.06 0.25 
130.08 1.64 
92.33 0.28 
94.47 0.24 
10.03 0.18 
0.67 0.01 
5.22 0.01 
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Table 8 A Average lipid and glycemic values (expressed as 51 units) 
for adults at risk for insulin resistance 
No.1 Mean S.E. 
Total Cholesterol (mmoIIL) 13793 5.23 0.02 
LDL Cholesterol (mmoljL) 13764 3.22 0.02 
HDL Cholesterol (mmoljL) 13765 1.33 0.01 
Triglycerides (mmol/L) 13794 1.47 0.02 
serum Glucose (mmoIjL) 13792 5.31 0.02 
Plasma Glucose (mmoIjL) 12819 5.24 0.01 
serum Insulin (pmol/L) 12784 60.17 1.06 
serum C-peptide (nmoIjL) 12825 0.67 0.01 
Glycated Hemoglobin (%) 13728 5.22 0.01 
1No.=unweighted sample size 
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Table 9 Average lipid and glycemic values for adults at risk for insulin 
resistance by gender 
Characteristics 
Total Cholesterol (mg{dL) 
LDL Cholesterol (mg{dL) 
HDL Cholesterol (mg{dL) 
Triglycerides (mg{dL) 
serum Glucose (mg/dL) 
Plasma Glucose (mg{dL) 
serum Insulin (uU/mL) 
serum C-peptide (pmol{mL) 
Glycated Hemoglobin (%) 
No.1 
6549 
6530 
6530 
6549 
6548 
6090 
6068 
6092 
6516 
Male
 
Mean
 
199.10 
124.97 
46.18 
140.36 
94.31 
96.51 
10.32 
0.69 
5.27 
S.E. 
0.78 
0.62 
0.30 
2.38 
0.28 
0.28 
0.22 
0.01 
0.01 
Female 
No. 1 Mean S.E. 
7244 202.76 0.85 
7234 123.06 0.78 
7235 55.59 0.33 
7245 120.51 1.63 
7244 90.49 0.35 
6729 92.58 0.27 
6716 9.76 0.17 
6733 0.65 0.01 
7212 5.17 0.01 
lNo.=unweighted sample size 
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Table 9 A Average lipid and glycemic values (expressed as 51 units) for 
adults at risk for insulin resistance by gender 
Characteristics
 
Total Cholesterol (mmoljL)
 
LDL Cholesterol (mmol/L)
 
HDL Cholesterol (mmoljL)
 
Triglycerides (mmol/L)
 
serum Glucose (mmol/L)
 
Plasma Glucose (mmol/L)
 
serum Insulin (pmol/L)
 
Serum C-peptide (nmol/L)
 
Glycated Hemoglobin (%)
 
Male 
No.1 Mean S.E. 
6549 5.18 0.02 
6530 3.25 0.02 
6530 1.20 0.01 
6549 1.59 0.,03 
6548 5.23 0.02 
6090 5.36 0.02 
6068 61.93 1.31 
6092 0.69 0.01 
6516 5.27 0.01 
No.1 
7244 
7234 
7235 
7245 
7244 
6729 
6716 
6733 
7212 
Female 
Mean S.E. 
5.27 0.02 
3.20 0.02 
1.45 0.01 
1.36 0.02 
5.02 0.02 
5.14 0.02 
58.54 1.02 
0.65 0.01 
5.17 0.01 
INo.=unweighted sample size 
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Table 10 Correlation between lipid and glycemic profiles and descriptive variablesl 
Physical Waist Number of 
Variables sex2 Age Activiti BMI4 circumference Risk Factors 
Total Cholesterol 0.039* 0.403* 0.001 0.242* 0.301* 0.265* 
LDL Cholesterol -0.065* 0.315* -0.053 0.246* 0.313* 0.171* 
HDL Cholesterol 0.322* 0.025* -0.013* -0.283* -0.343* -0.241* 
Triglycerides -0.132* 0.261* 0.013 0.381* 0.299* 0.524* 
Serum Glucose -0.151* 0.326* -0.003 0.259* 0.325* 0.354* 
VI 
0- Plasma Glucose -0.162* 0.314* 0.001 0.245* 0.320* 0.351 * 
Serum Insulin 0.038* 0.091* -0.017 0.578* 0.562* 0.349* 
Serum C-peptide 0.038* 0.245* -0.000 0.559* 0.593* 0.384* 
Glycated Hemoglobin -0.085* 0.390* -0.007 0.237* 0.291 * 0.263* 
lValues reported as Pearson-product-moment correlation coefficient r, * indicates significance (p<.05) 
21=Male, 2=Female 
3METs=metabolic equivalents 
4BMI=body mass index wrg/hrn2 
Table 11 Correlation between lipid and glycemic profiles and dietary variables1 
Variables 
Total Cholesterol 
Total Protein 
-0.051* 
Animal Protein 
-0.034* 
Fat 
-0.067* 
saturated Fat 
-0.063* 
carbohydrate 
-0.119* 
Dietary fiber 
-0.005 
LDL Cholesterol -0.005 -0.012 -0.004 -0.000 -0.046* -0.002 
HDL Cholesterol 
-0.093* -0.073* -0.086* -0.088* -0.157* -0.026* 
Triglycerides -0.010 -0.007 -0.030* -0.022 -0.038* 0.051 * 
VI 
-l 
Serum Glucose 
Plasma Glucose 
-0.005 
-0.000 
-0.001 
~0.005 
-0.022 
-0.029* 
-0.018 
-0.017 
-0.010 
-0.019 
0.027* 
0.012 
Serum Insulin -0.004 -0.019 -0.003 -0.014 -0.009 -0.063* 
Serum C-peptide -0.017 -0.010 -0.005 -0.015 -0.049* -0.052* 
Glycated Hemoglobin -0.020* -0.010 -0.040* -0.038* -0.045* 
lValues reported as Pearson-product-moment correlation coefficient r, * indicates significance (p<.05) 
-0.009 
Table 12 Differences in lipid and glycemic profiles by total protein quartilesl-2 
<25 25-5Q 50-75 75-100 
Variables Mean S.E. Mean S.E. Mean S.E. Mean S.E. P 
Total Cholesterol (mg/dL) 204.8Sa 1.12 201.01b 0.87 201.6gab 1.18 197.18c 1.03 <0.0067 
LDL Cholesterol (mg/dL) 126.60 1.01 122.95 1.00 124.70 1.08 122.09 0.80 <0.3286 
HDL Cholesterol (mg/dL) 52.31a 0.45 52.67a 0.41 50.86b 0.42 48.79c 0.32 <0.0263 
Triglycerides (mg/dL) 129.73 2.42 127.37 2.49 130.87 2.01 132.03 2.33 <0.2161 
VI 
00	 Serum Glucose (mg/dL) 92.41 0.39 92.36 0.39 92.19 0.41 92.37 0.47 <0.9466 
Plasma Glucose (mg/dL) 94.74 0.41 94.39 0.29 94.20 0.41 94.59 0.38 <0.5716 
Serum Insulin (uU/mL) lO.32a 0.30 9.57b 0.19 lO.Ola 0.25 10.23a 0.25 <0.0117 
Serum C-peptide (pmol/mL) 0.70a 0.01 0.65b 0.01 0.67a 0.01 O.6Gb 0.01 <0.0042 
Glycated Hemoglobin (%) 5.23 0.02 5.23 0.02 5.22 0.01 5.20 0.02 <0.8569 
lMeans in a row with different superscripts are significantly different (p<.05) 
2Model includes following covariates: age, sex, BM!, waist circumference, lifestyle factors (physical activity and alcohol 
consumption), dietary intake (fat and carbohydrate), and number of risk factors 
Table 12 A Differences in lipid and glycemic profiles (expressed in 51 units) by total protein quartilesl -2 
<25 25-50 50-75 75-100 
Variables Mean S.E. Mean S.E. Mean S.E. Mean S.E. P 
Total Cholesterol (mmoI/L) 5.33a 0.03 5.23b 0.02 5.24ab 0.03 5.13c 0.03 <0.0067 
LDL Cholesterol (mmoIlL) 3.29 0.03 3.20 0.03 3.24 0.03 3.17 0.02 <0.3286 
HDL Cholesterol (mmoI/L) 1.36a 0.01 1.37a 0.01 1.32b 0.01 1.2JC 0.01 <0.0263 
Triglycerides (mmoIlL) 1.47 0.03 1.44 0.03 1.48 0.02 1.49 0.03 <0.2161 
VI Serum Glucose (mmoIlL) 5.13 0.02 5.13 0.02 5.12 0.02 5.13 0.03 <0.9538 \D 
Plasma Glucose (mmoIlL) 5.26 0.02 5.24 0.02 5.23 0.02 5.25 0.02 <0.5968 
Serum Insulin (pmoIlL) 61.91a 1.80 57.41b 1.14 6O.04a 1.49 61.39a 1.49 <0.0106 
Serum C-peptide (nmol/L) 0.70a 0.01 0.65b 0.01 0.67a 0.01 O.66b 0.01 <0.0042 
Glycated Hemoglobin (%) 5.23 0.02 5.23 0.02 5.22 0.01 5.20 0.02 <0.8569 
IMeans in a row with different superscripts are significantly different (p< .05) 
2Model includes following covariates: age, sex, BMI, waist circumference, lifestyle factors (physical activity and alcohol 
consumption), dietary intake (fat and carbohydrate), and number of risk factors 
2Table 13 Differences in lipid and glycemic profiles by animal protein quartilesl­
<25 25-50 50~75 75-100 
Variables Mean S.E. Mean S.E. Mean S.E. Mean S.E. P 
Total Cholesterol (mg/dL) 202.93a 1.13 201.30a 0.92 202.68a 1.18 197.50b 1.03 <0.0017 
LDL Cholesterol (mg/dL) 124.78 0.99 123.73 0.97 125.18 1.16 122.39 0.79 <0.1998 
HDL Cholesterol (mg/dL) 52.01a 0.42 52.01a 0.50 51.56a 0.44 48.93b 0.33 <0.0310 
Triglycerides (mg/dL) 131.18 2.50 127.85 2.42 129.75 2.12 131.43 2.20 <0.5003 
0\ Serum Glucose (mg/dL) 92.51 0.34 92.21 0.43 92.19 0.42 92.41 0.45 <0.62280 
Plasma Glucose (mg/dL) 94.53 0.40 94.47 0.30 94.29 0.40 94.59 0.37 <0.4978 
Serum Insulin (uU/mL) 10.148 0.27 9.42b 0.20 10.16a 0.24 10.36a 0.23 <0.0084 
Serum C-peptide (pmol/mL) 0.68 0.01 0.66 0.01 0.67 0.01 0.67 0.01 <0.7109 
Glycated Hemoglobin (%) 5.23 0.02 5.23 0.02 5.22 0.01 5.20 0.02 <0.2209 
lMeans in a row with different superscripts are significantly different (p<.05) 
2Model includes follOWing covariates: age, sex, BMI, waist circumference, lifestyle factors (physical actiVity and alcohol 
consumption), dietary intake (fat and carbohydrate), and number of risk factors 
Table 13 A Differences in lipid and glycemic profiles (expressed in 51 units) by animal protein quartilesl-2 
<25 ~ 50-75 75-100 
Variables Mean S.E. Mean S.E. Mean S.E. Mean S.E. P 
Total Cholesterol (mmoIlL) 5.28a 0.03 5.23a 0.02 5.27a 0.03 5.14b 0.03 <0.0017 
LDL Cholesterol (mmoIlL) 3.24 0.03 3.22 0.03 3.25 0.03 3.18 0.02 <0.1998 
HDL Cholesterol (mmoIlL) 1.35a 0.01 1.35a 0.01 1.34a 0.01 1.27b 0.01 <0.0310 
Triglycerides (mmoI/L) 1.48 0.03 1.44 0.03 1.47 0.02 1.49 0.02 <0.5003 
0\ Serum Glucose (mmoIlL) 5.13 0.02 5.12 0.02 5.12 0.02 5.13 0.03 <0.6458
-
Plasma Glucose (mmoIlL) 5.25 0.02 5.24 0.02 5.23 0.02 5.25 0.02 <0.5142 
Serum Insulin (pmoIlL) 6O.86a 1.64 56.52b 1.19 6O.95a 1.43 62.15a 1.41 <0.0120 
Serum C-peptide (nmoIlL) 0.68 0.01 0.66 0.01 0.67 0.01 0.67 0.01 <0.7109 
Glycated Hemoglobin (%) 5.23 0.02 5.23 0.02 5.22 0.01 5.20 0.02 <0.2209 
lMeans in a row with different superscripts are significantly different (p<.05) 
2Model includes following covariates: age, sex, BMI, waist circumference, lifestyle factors (physical activity and alcohol 
consumption), dietary intake (fat and carbohydrate), and number of risk factors 
l 2Table 14 Differences in lipid and glycemic profiles by total protein quartiles for men and women -
Variables sex <25 25-50 50-75 75-100 P 
Total Cholesterol (mg/dL) M 201.84±2.411 197.24±1.431 202.09±1.336 197.32±1.071 <0.0366 
F 205.78±1.14 203.23±1.17 201.29±1.71 196.76±2.34 <0.3902 
LDL Cholesterol (mg/dL) M 127.95±2.02 122.25±1.49 127.53±1.23 123.78±0.93 <0.4095 
F 126. 18±1.05 123.36±1.19 121.83±1.46 116.74±1.80 <0.5555 
HDL Cholesterol (mg/dL) M 45.59±0.68 46.89±0.64 45.38±0.45 46.51±0.38 <0.1136 
F 54.38±0.46 56.05±0.54 56.42±0.59 55.97±0.58 <0.1867 
Triglycerides (mg/dL) M 141.32±4.32 141.57±4.48 146.46±4.16 135.72±2.67 <0.2159 
F 126.15±2.66 119.03:2.12 114.95±2.61 120.38±4.10 <0.1330 
serum Glucose (mg/dL) M 97.03±1.06 94.43±0.42 94.44±0.42 93.49±0.49 <0.4790 
0\ 
N F 9O.98±0.40 91.14±0.51 89.89±0.56 88.84±0.70 <0.6126 
Plasma Glucose (mg/dL) M 99.41±1.17 96.38±0.47 96.56±0.46 95.79±0.38 <0.4463 
F 93.29±0.38 93.22±0.35 91.76±0.51 9O.81±0.66 <0.3678 
serum Insulin (j.JU/mL) M 11.4O±0.64 9.79±0.33 10.30±0.36 10.30:0.27 <0.1529 
F 9.982±0.27 9.44±0.02 9.71±0.23 10.02±0.46 <0.0775 
Serum C-Peptide (pmol/mL) M 0.77±0.03 0.68±0.02 0.71±0.02 0.66±0.01 <0.2232 
F 0.68±0.011 0.64±0.0111 0.64±0.0111 0.66±0.031 <0.0147 
Glycated Hemoglobin (%) M 5.37±0.04 5.27±0.02 5.29±0.02 5.22±0.02 <0.3791 
F 5.19±0.02 5.20±0.02 5.14±0.02 5.12±0.02 <0.6790 
IMeans in a row with different superscripts are significantly different (p< .05) 
2Model includes following covariates: age, sex, 8MI, waist circumference, lifestyle factors (physical actiVity and alcohol consumption), 
dietary intake (fat and carbohydrate), and number of risk factors 
Table 14 A Differences in lipid and glycemic profiles (expressed as 51 units) by total protein quartiles for men and 
2womenl ­
Variables sex <25 25-50 50-75 75-100 P 
Total Cholesterol (mmoIjL) M 5.25±0.06a 5.13±0.04a 5.25±0.036 5.13±0.03a <0.0336 
F 5.35±0.03 5.28±0.03 5.23±0.04 5.12±0.06 <0.3902 
LDL Cholesterol (mmoIjL) M 3.33±0.05 3.18±0.04 3.32±0.03 3.22±0.02 <0.4095 
F 3.28±0.03 3.21±0.03 3.17±0.04 3.04±0.05 <0.5555 
HDL Cholesterol (mmol/L) M 1.19±0.02 1.22±0.02 1.18±0.01 1.21±0.01 <0.1136 
F 1.41±0.01 1.46±0.01 1.47±0.02 1.46±0.02 <0.1867 
Triglycerides (mmol/L) M 1.60±0.05 1.60::1:0.05 1.65±0.05 1.53±0.03 <0.2159 
F 1.43±0.03 1.35±0.02 1.30±0.03 1.36±0.05 <0.1330 
Q\ Serum Glucose (mmol/L) M 5.39±0.06 5.24±0.02 5.24±0.02 5.19±0.03 <0.4855 
w 
F 5.05±0.02 5,06±0.03 4.99±0.03 4.93±0.04 <0.6021 
Plasma Glucose (mmol/L) M 5.52:i:0.06 5.35±0.03 5.36±0.03 5.32±0.02 <0.4554 
F 5.18±0.02 5.17±0.02 5.09±0.03 5.04±0.04 <0.3747 
Serum Insulin (pmoIjL) M 68.38±3.83 58.74±1.98 61.77±2.14 ·61.79±1.61 <0,1489 
F 59.90±1.61 56.64±1.19 58.26±1.40 60.12±2.78 <0.0670 
Serum C-peptide (nmol/L) M 0.77±0.03 0.68±0.02 0.71±0.02 0.66±0.01 <0.2232 
F 0.68±0.01a O.64±O.Ola O.64±O.Ola 0.66±0.03a <0.0147 
Glycated Hemoglobin (%) M 5.37±0.04 5.27±0.02 5.29±0.02 5.22±0.02 <0.3791 
F 5.19±0.02 5.20±0.02 5.14±0.02 5.12±0.02 <0.6790 
lMeans in a row with different superscripts are significantly different (p<.05) 
2Model includes following covariates: age, sex, BMI, waist circumference, lifestyle factors (physical actiVity and alcohol consumption), 
dietary intake (fat and carbohydrate), and number of risk factors 
Table 15 Differences in lipid and glycemic profiles by animal protein quartiles for men and women l -2 
Variables 
Total Cholesterol (mg/dL) 
sex 
M 
F 
<25 
198.35±2.361 
204.70±1.201 
25-50 
198.29±1.411 
203.26±1.15Ib 
50-75 
203.11±1.39b 
202.28±1.59bc 
75-100 
197.23±1.071 
198.24±2.12c 
P 
<0.0366 
<0.0382 
LDL Cholesterol (mg/dL) M 124.65±1.95 123.64±1.S8 127.98±1.48 123.84±0.89 <0.6847 
F 124.83±1.12 123.79±1.11 122.58±1.35 118.46±1.77 <0.0713 
HDL Cholesterol (mg/dL) M 45.04±0.6S 46.73±0.73 46.03±0.47 46.37±0.39 <0.0522 
F S4.70±0.46 55.45±0.47 56.70±0.65 55.88±0.65 <0.1540 
Triglycerides (mg/dL) M 144.74±4.47 139.66±4.23 146.01±3.84 135.78±2.79 <0.0704 
F 125.93±2.77 120.16±1.93 114.57±2.45 119.64±3.39 <0.4428 
0\ 
Jl,. 
serum Glucose (mg/dL) M 
F 
96.27±0.74 
91.05±0,40 
94.29±0.62 
90.85±0.48 
94.53±0.42 
90.01±0.61 
93.54±0.47 
89.3S±0.65 
<0.8653 
<0.7815 
Plasma Glucose (mg/dL) M 98.4S±0.90 96.52±0.S9 96.5S±0.39 95.83±0.37 <0.8321 
serum Insulin (~U/mL) 
F 
M 
92.99±0,42 
10.96±0.441 
93.14±0.31 
9,43±0.38b 
92.14±0.56 
10.48±0.331 
91.28±O.61 
10.4S±O.2aa 
<0.6103 
<0.0034 
F 9.82±0.27 9,42±O.16 9.8S±0.29 10. 12±0.39 <0.3707 
serum C-peptide (pmol/mL) M 
F 
0.73±0.02 
0.66:1:0.01 
0.66±0.01 
0.6S±0.01 
0.71±0.O2 
0.64±0.02 
0.67±0.01 
0.67±0.02 
<0.3264 
<0.2000 
Glycated Hemoglobin (%) M 
F 
5.33±0.02 
5.19±0.02 
5.28±0.03 
5.19±0.02 
5.28±0.02 
S.lS±0.02 
5.23±0.02 
S.14±0.03 
<0.6533 
<0.1806 
lMeans in a row with different superscripts are significantly different (p<.OS) 
2Model includes following covariates: age, sex, 8MI, waist circumference, lifestyle factors (physical actiVity and alcohol consumption), 
dietary intake (fat and carbohydrate), and number of risk factors 
Table 15 A Differences in lipid and glycemic profiles (expressed as 51 units) by animal protein quartiles for men and 
women1-2 
Variables Sex <25 25-50 50-75 75-100 P 
Total Cholesterol (mmol/L) M 5.16±0.06a 5.16±0.04a 5.28±0.046 5.13±0.0311 <0.0366 
F 5.32±0.03a 5.28±0.03ab 5.26±0.04bc 5.1S±0.06c <0.0382 
LDL Cholesterol (mmol/L) M 3.24±0.05 3.21±0.04 3.33±0.04 3.22±0.02 <0.6847 
F 3.2S±0.03 3.22±O.03 3.19±0.04 3.08±0.05 <0.0713 
HDL Cholesterol (mmol/L) M 1.17±O.02 1.21±0.02 1.20±0.Ol 1.21±0.01 <0.0522 
F 1.42±0.00 1.44±0.01 1.47±0.02 1.4S±0.02 <0.1540 
Triglycerides (mmoIlL) M 1.64±0.05 l.S8±0.05 1.65±0.04 l.S3±0.03 <0.0704 
F 1.42±0.03 1.36±0.02 1.29±0.03 1.3S±0.04 <0.4428 
0\ Serum Glucose (mmol/L) M 5.34±0.04 5.23±0.03 5.25±0.02 5.19±O.03 ·<0.8596 
VI 
F 5.05±0.02 5.04±0.03 5.00±0.03 4.96±0.04 <0.7943 
Plasma Glucose (mmol/L) M 5.47±0.05 5.36±0.03 5.36±0.02 5.32±0.02 <0.8309 
F 5.16±0.02 5.17±0.02 5.11±0.03 5.07±0.03 <0.6107 
Serum Insulin (pmol/L) M 65.77±2.66a 56.55±2.28b 62.88±1.96a 62.69±1.67i1 <0.0036 
F 58.95±1.64 56.49±0.98 59.13±1.72 60.69±2.32 <0.4265 
serum C-Peptide (nmol/L) M 0.73±0.02 0.66±0.01 0.71±0.02 0.67±0.01 <0.3264 
F 0.66±0.01 0.65±0.01 0.64±0.02 0.67±0.02 <0.2000 
Glycated Hemoglobin (%) M 5.33±0.02 5.28±0.03 5.28±0.02 5.23±0.02 <0.6533 
F 5.19±0.02 5.19±0.02 5.15±0.02 5.14±0.03 <0.1806 
IMeans in a row with different superscripts are significantly different (p< .05) 
2Model includes follOWing covariates: age, sex, BMI, waist: circumference, lifestyle factors (physical activity and alcohol consumption), 
dietary intake (fat and carbohydrate), and number of risk factors 
CHAPTER V
 
DISCUSSION 
As described earlier, the purpose of the present study was to investigate 
the relationship of protein intake with lipoprotein profiles (total cholesterol, LDL 
cholesterol, HDL cholesterol, triglycerides) and glycemic profiles (fasting and 
postprandial glucose and insulin, C-peptide, and hemoglobin A1c) in adults who 
were at risk of insulin resistance. The study used data from a nationally 
representative sample of the US civilian non-institutionalized population from 
NHANES III (1988-1994). The results of this study did not demonstrate a 
consistent association between total and animal dietary protein intakes and 
glycemic and lipoprotein profiles. 
Dietary Intake 
. 
The overall dietary pattern for the U.S. population reported by NHANES 
III and our samples are almost identical: 34%/355% energy from fat, 
15%/14.90/0 of energy from protein, 50% /49.7% of energy from carbohydrate, 
respectively (McDowell et aI., 1994). The mean protein intakes were also similar 
between our samples and NHANES III estimates; both samples showed similar 
gender differences (men consumed greater amounts of protein than women) and 
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exceeded the RDA in both gender groups. Smit et al. (19996) conducted a study 
describing detailed protein sources using the NHANES III data. They found that 
the main protein source in the US diet is animal protein, with most of the animal 
protein coming from the combination of meat, fish, and poultry, followed by 
dairy protein. With respect to the specific animal protein sources, beef protein 
contributed the most, followed by milk and yogurt protein. Most of the plant 
protein came from grains. They also reported that the consumption of animal 
protein had nearly doubled when compared to data collected by carroll (1982). 
In the present study, 67.8% of total protein came from animal sources. 
Lipid Profiles 
Many studies examined the association between lipid and/or glycemic 
profiles and health or nutritional status. Very few articles focus directly on 
specific nutrients, and those that do tend to focus on nutrients that are 
considered unhealthy if consumed in excess such as saturated fat and cholesterol. 
There are limited studies that examine the protein intake and its effects on 
human health. Unlike most other studies, the present study focuses on total 
protein and animal protein and lipid and glycemic profiles. 
Wolfe and Piche (1999) reported that moderate replacement of dietary 
carbohydrate with low-fat, high-protein foods in a diet significantly improved 
plasma lipoprotein cardiovascular risk profiles in healthy humans. Similarly, the 
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results of present study showed that total cholesterol was higher with lower 
protein intake (both total and animal protein intake) when controlled for lifestyle 
variables. No differences were found for LDL cholesterol. Interestingly, our 
findings were different from results of Smit et at. (1999A) that found the positive 
association between animal protein intake and cholesterol concentrations. 
However, Coggins et al. (1994) reported that serum total and LDL cholesterol 
levels tended to decrease with reduced protein intake. 
A number of investigations have shown that a vegetable protein diet 
results in lower plasma levels of cholesterol in humans and animals compared to 
animal protein diets. (Carroll and Hamilton, 1975; Kritchevsky, 1979; Zulet and 
Martinez, 1995) Yamada et al. (1987) suggested that a high intake of animal 
protein would cancel or diminish the hypocholesterolemic effect of vegetable 
protein diet and physical exercise. However, we found that people who 
consumed less animal protein had higher total cholesterol. 
Besides the difference in types of protein, there are several other 
concerns to point out the direct relationship between protein intake and lipid 
profiles, since most foods containing protein also contain other nutrients such as 
fat. Although our analyses controlled for the amount of fat and carbohydrate in 
the diet, it is almost impossible to avoid the effects of nutrient and biological 
interactions since most meals are a mixture of various food items that contain 
many nutrients. 
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Glycemic Profiles, 
In the current study, risk of insulin resistance was assessed by BMI, waist 
circumference, serum triglycerides, blood glucose or family history of diabetes 
and a high BMI was most common risk factor (71.3%) for both men and women. 
Trichopoulou et al. (2002) examined the relation between intake of protein and 
BMI and suggested that a high protein intake was conducive to obesity. 
Many studies, both recent and old, have examined the insulin resistance, 
metabolic syndrome, and their dietary treatment. Insulin resistance and 
metabolic syndrome is the cause of major health prob'lems in US. Many articles 
focus on risk factors of insulin resistance, etiology of metabolic syndrome, 
treatment of insulin resistance. The Oslo Diet and Exercise Study reported that 
increased protein intake with a reduced fat intake was effective in decreasing 
both fasting serum glucose and insulin levels in overweight adults with mildly 
elevated blood pressure and lipids (Torjesen et ai, 1997). They also found that 
C-peptides were reduced more with the exerciseintelVention than the diet 
intervention. However, no published study examined the association !between 
protein consumption and glycemic profiles of individuals at risk for insulin 
resistance. In the current study, we found no significant association between 
protein intake and insulin or C-peptide concentrations. 
69
 
Limitations 
One of the main limitations of this study was the use of self-reported 
information, which may not be accurate and may give inconsistent results. 
Participants in the survey may have answered questions based on what they 
thought was correct and not on what they actually did. 
Dietary risk factors are notoriously difficult to study and the 24-hour recall 
data are presumably only rough estimators of average intake of individuals. High 
correlations among intakes of fat, protein, and other nutrients make it difficult to 
single out the nutrient responsible for affecting lipid and glycemic profiles and 
associated risk of insulin resistance, diabetes, and cardiovascular diseases. 
Also the questions asked on the original study were not specifically developed to 
meet the needs of the current study to investigate the relations between protein 
intake and lipid and glycemic profiles. 
Conclusion 
For both total cholesterol and HDL cholesterol, this study showed that 
average values were higher in the group with the lowest protein intake after 
controlling for age, sex, 8MI, waist circumference, lifestyle factors (physical 
actiVity and alcohol consumption), dietary intake (fat and carbohyderate), and 
number of risk factors·. This study also showed that totat cholesterol levels 
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decreased as animal protein intake increased in women. Other lipid values (LDL 
and triglycerides) did not vary by quartiles of protein intake. 
The present study found that the Americans consumed sufficient amount 
of dietary protein based on RDA and average HDL cholesterol, triglycerides, and 
glycemic values were within the normal range for both genders. sex, age, 8MI, 
waist circumference, family history, and number of risk factors were associated 
with all lipid and glycemic profiles. All lipid (except HDL cholesterol) and 
glycemic profiles, 8MI, waist circumference, and number of risk factors were 
higher in participants who were older, more obese (higher 8MI), had a more 
andoroid shape (higher waist circumference), and more risk factors for insulin 
resistance. 
Implications 
Most people in the US are consuming enough protein, probably too much 
protein from the animal sources. However, most research findings reported 
benefits of increased vegetable protein intake, rather than animal protein intake. 
Such findings are not practical to apply to a population that consumed more 
animal protein than vegetable protein. 
As the evidence mounts for a relationship between protein intake and 
glycemic and lipid profiles" it may become increasingly important to evaluate the 
status of these nutrients in patients with insulin resistance, diabetes, and 
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cardiovascular diseases. At present, it remains unclear whether a high protein 
intake provides an additional benefit over a lower protein intake to reduce 
diabetes and cardiovascular risk in individuals who exhibit characteristics that 
Increase their risk of insulin resistance. 
Future Research 
Further investigations under controlled clinical settings with precise 
protein intake measurements are needed to determine the effect of protein on 
glycemic and lipid profiles in individuals with metabolic syndrome, and related 
chronic diseases such as diabetes and cardiovascular disease. Because we could 
not find studies that reported strong beneficial effects of protein intake on 
glycemic control, further studies on this area should be helpful to deepen our 
understanding. In addition, researchers should consider assessing the effect of 
nutrition education on protein intake to minimize the risk of further metabolic 
complications such as diabetes and cardiovascular diseases. 
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